What is it about?
In the current study we showed that high quantity of the SARS-CoV-2 in the nasopharynx swabs from infected patients 7-18 days post symptoms is associated with the deterioration of patients’ medical conditions, leading to hospitalization. At the same time, we showed that at the common dose therapy with hydroxychloroquine has no effect on the coronavirus infection.
Featured Image
Photo by Viktor Forgacs on Unsplash
Why is it important?
The results of this study, together with the results of recently published works, indicate that SARS-CoV-2 quantity determined using quantitative methods can be a prospective approach for monitoring of COVID-19 course and prediction of deterioration in patient condition.
Read the Original
This page is a summary of: High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration, PLoS ONE, January 2021, PLOS,
DOI: 10.1371/journal.pone.0246396.
You can read the full text:
Contributors
The following have contributed to this page
